Bisphosphonate as a potential new treatment for CV risk reductionAug. 27, 2016 - ESC, Rome, Italy - Guido Kranenberg (Utrecht, The Netherlands)
CSI Rome Guido Kranenberg (UMC Utrecht, The Netherlands) studied the potential impact of bisphosphonate on calcification of the arterial intima media. He shares the findings of a systematic review and meta-analysis with Nicole Jaspers (UMC Utrecht, The Netherlands) and they discuss which other studies might shed light on this relationship.
- Bisphosphonate might impact arterial calcification 0:57
- Two types of arterial wall disease culminate in calcification 1:30
- Reviewing studies that evaluate the effect of bisphosphonates on CV morbidity and mortality 2:52
- A differential impact on cardiovascular and vascular mortality 4:24
- The CV effect of an agent generally used for osteoporosis deserves its own study 5:05
- Pseudo Xanthoma Elastica (PXE) as a model disease to evaluate the effect of bisphosphonate on the intima media 6:40
In the Cardiovascular Scene Investigation (CSI) series, young clinicians with an investigative mindset interview experts about the context and meaning of the results they just presented at the ESC congress.
The series is aimed to explore the background and practical implications of recent scientific developments, like those discussed in the Rapid Fire session called 'Breaking Down Barriers in Secondary Prevention' at the ESC Congress 2016, with speakers in this session.
Faculty & Disclosures
Guido Kranenberg - UMC Utrecht, The Netherlands
Nicole Jaspers - UMC Utrecht, The Netherlands
The speakers did not receive financial compensation for participating in these interviews